Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Specialties
Publications
Articles from Nancy Dvorin:
Read all from this author
Perspective & Commentary

Digital Edition: Market Pathways August 2025

  • 2025-08-01 00:00:00.0
  • Nancy Dvorin
  • Market Pathways

Balancing the need for clinical vs non-clinical data to meet EU clinical evaluation requirements for moderate-risk devices; DOJ's Data Security Program mandates tighter control over data going to entities in China and other countries of concern; Little clarity on the number of laid-off vs. reinstated staffers; UK's MHRA proposes indefinite recognition of CE-marked devices, streamlines review of other countries' products; FDA's user fees on the rise; Recent FDA digital device authorizations

Read Article